Real-world comparative effectiveness of rivaroxaban versus heparin and phenprocoumon for the treatment and secondary prevention of venous thromboembolism (RECENT)First published 30/06/2020 Last updated 23/04/2024 EU PAS number: EUPAS36102StudyFinalised